Ha habido 50 transacciones internas recientes registradas para Cellectar Biosciences, Inc. (CLRB), incluyendo 46 compras y 3 ventas. El total de compras internas fue valorado en $8.96M y el total de ventas internas en $731.99.
Internos destacados con actividad reciente incluyen Neis John, Caruso James V, Longcor Jarrod. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CLRB
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-12-12 |
Neis John |
Director |
Venta Informativa |
198 |
$3.70 |
$731.99 |
10 |
| 2025-07-02 |
Caruso James V |
Chief Executive Officer |
Compra Informativa |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Longcor Jarrod |
Chief Operating Officer |
Compra Informativa |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Kolean Chad J |
Chief Financial Officer |
Compra Informativa |
5,000 |
$5.25 |
$26.25K |
5,000 |
| 2025-02-14 |
Driscoll Frederick W |
Director |
Concesión de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Neis John |
Director |
Concesión de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Caruso James V |
President and CEO |
Concesión de RSU |
900,000 |
$0.29 |
$261K |
900,000 |
| 2025-02-14 |
Swirsky Douglas J |
Director |
Concesión de RSU |
90,000 |
$0.29 |
$26.1K |
90,000 |
| 2025-02-14 |
Loren Stefan |
Director |
Concesión de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Longcor Jarrod |
Chief Operating Officer |
Concesión de RSU |
500,000 |
$0.29 |
$145K |
500,000 |
| 2025-02-14 |
Kolean Chad J |
Chief Financial Officer |
Concesión de RSU |
290,000 |
$0.29 |
$84.1K |
290,000 |
| 2025-02-14 |
Chanan-khan Asher |
Director |
Concesión de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-01-10 |
Longcor Jarrod |
Chief Operating Officer |
Compra Informativa |
30,000 |
$0.28 |
$8.4K |
83,141 |
| 2024-06-14 |
Driscoll Frederick W |
Director |
Concesión de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Neis John |
Director |
Concesión de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Caruso James V |
President and CEO |
Concesión de RSU |
900,000 |
$2.65 |
$2.39M |
900,000 |
| 2024-06-14 |
Swirsky Douglas J |
Director |
Concesión de RSU |
90,000 |
$2.58 |
$232.2K |
90,000 |
| 2024-06-14 |
Loren Stefan |
Director |
Concesión de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Longcor Jarrod |
Chief Operating Officer |
Concesión de RSU |
500,000 |
$2.65 |
$1.33M |
500,000 |
| 2024-06-14 |
Kolean Chad J |
Chief Financial Officer |
Concesión de RSU |
290,000 |
$2.65 |
$768.5K |
290,000 |
| 2024-06-14 |
Chanan-khan Asher |
Director |
Concesión de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Lea Darrell Shane |
Chief Commercial Officer |
Concesión de RSU |
260,000 |
$2.65 |
$689K |
260,000 |
| 2024-06-14 |
Shustov Andrei |
Senior Vice President, Medical |
Concesión de RSU |
260,000 |
$2.65 |
$689K |
260,000 |
| 2023-12-08 |
Caruso James V |
President and CEO |
Concesión de RSU |
40,596 |
- |
- |
49,236 |
| 2023-12-08 |
Longcor Jarrod |
Chief Operating Officer |
Concesión de RSU |
42,927 |
- |
- |
53,141 |
| 2023-12-08 |
Kolean Chad J |
Chief Financial Officer |
Concesión de RSU |
42,554 |
- |
- |
42,578 |
| 2023-12-08 |
Lea Darrell Shane |
Chief Commercial Officer |
Concesión de RSU |
39,599 |
- |
- |
39,599 |
| 2023-12-08 |
Shustov Andrei |
Senior Vice President, Medical |
Concesión de RSU |
47,856 |
- |
- |
55,038 |
| 2023-06-28 |
Driscoll Frederick W |
Director |
Concesión de RSU |
25,000 |
$1.85 |
$46.25K |
47,650 |
| 2023-06-28 |
Neis John |
Director |
Concesión de RSU |
25,000 |
$1.85 |
$46.25K |
47,887 |
| 2023-06-28 |
Swirsky Douglas J |
Director |
Concesión de RSU |
37,500 |
$1.85 |
$69.38K |
71,925 |
| 2023-06-28 |
Loren Stefan |
Director |
Concesión de RSU |
25,000 |
$1.85 |
$46.25K |
47,885 |
| 2023-06-28 |
Chanan-khan Asher |
Director |
Concesión de RSU |
25,000 |
$1.85 |
$46.25K |
40,600 |
| 2023-06-23 |
Caruso James V |
President and CEO |
Concesión de RSU |
261,000 |
$1.68 |
$438.48K |
261,000 |
| 2023-06-23 |
Longcor Jarrod |
Chief Operating Officer |
Concesión de RSU |
144,000 |
$1.68 |
$241.92K |
144,000 |
| 2023-06-23 |
Kolean Chad J |
Chief Financial Officer |
Concesión de RSU |
104,000 |
$1.68 |
$174.72K |
104,000 |
| 2023-06-23 |
Lea Darrell Shane |
Chief Commercial Officer |
Concesión de RSU |
100,000 |
$1.68 |
$168K |
100,000 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
Disposición |
- |
- |
- |
7,182 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
Concesión de RSU |
100,000 |
$1.67 |
$167K |
100,000 |
| 2023-01-17 |
Caruso James V |
President and CEO |
Concesión de RSU |
261,000 |
- |
- |
261,000 |
| 2023-01-17 |
Longcor Jarrod |
Chief Operating Officer |
Concesión de RSU |
144,000 |
- |
- |
144,000 |
| 2023-01-17 |
Kolean Chad J |
Chief Financial Officer |
Concesión de RSU |
104,000 |
- |
- |
104,000 |
| 2022-11-21 |
Lea Darrell Shane |
Officer |
Desconocido |
- |
- |
- |
- |
| 2022-11-21 |
Lea Darrell Shane |
Chief Commercial Officer |
Concesión de RSU |
100,000 |
- |
- |
100,000 |
| 2022-06-24 |
Driscoll Frederick W |
Director |
Concesión de RSU |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Neis John |
Director |
Concesión de RSU |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Swirsky Douglas J |
Director |
Concesión de RSU |
11,700 |
$4.10 |
$47.97K |
11,700 |
| 2022-06-24 |
Loren Stefan |
Director |
Concesión de RSU |
7,800 |
$4.10 |
$31.98K |
7,800 |
| 2022-06-24 |
Chanan-khan Asher |
Director |
Concesión de RSU |
7,800 |
- |
- |
7,800 |
| 2022-02-24 |
Kolean Chad J |
Chief Financial Officer |
Disposición |
- |
- |
- |
240 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
